Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... 50% of predicted as measured by standard PFTs Total bilirubin < 2.0 (unless diagnosis of Gilbert's or hemolysis is ...

    Clinical Trial last updated 05/09/2016 - 3:36pm.

  2. Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies

    ... for hemoglobin . Adequate liver function: a. Bilirubin </= 1.5 mg/dl (unless Gilbert's syndrome). b. SGPT </= 200 IU/ml ...

    Clinical Trial last updated 06/06/2016 - 1:18pm.

  3. Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children

    ... who have liver function test (LFTs) (including total bilirubin , aspartate aminotransferase [AST] and alanine aminotransferase ...

    Clinical Trial last updated 06/13/2016 - 2:29pm.

  4. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... Hepatic: < 3x ULN ALT and < 2.0x ULN total serum bilirubin , unless there is congenital benign hyperbilirubinemia. Renal: ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  5. Safety and Effect of GL-ONC1 Administered IV With or Without Eculizumab Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery

    ... creatinine ≤ 1.5 × upper limit of normal (ULN); Bilirubin ≤ 1.5 × ULN; ALT and AST at ≤ 2.5 × ULN (in case of ...

    Clinical Trial last updated 04/28/2016 - 1:57pm.

  6. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    ... or equal to 35% or shortening fraction less than 25% Bilirubin greater than or equal to 3.0 mg/dL (unless due to Gilbert's ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.

  7. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... to appropriate therapy h.         Total bilirubin ≥ 1.5 mg/dL not related to hemolysis or Gilbert’s ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  8. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... by pulse oximetry. c. Creatinine < 1.6 mg/dL. d. SGPT/ bilirubin </= to 2.0 x normal. Negative Beta HCG test in a woman with ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.

  9. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... Hepatic: < 3x ULN AST and ≤ to 1.5 total serum bilirubin , unless there is congenital benign hyperbilirubinemia or if the ... Chloroma obstructing the biliary tree). Patients with higher bilirubin levels due to causes other than active liver disease are also ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  10. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... clearance or GFR) > 40mL/min/1.73 m2. SGPT/ bilirubin < to 2.0 x normal (Myeloablative Regimen 1), Reduced Intensity Regimen 3. SGPT/bilirubin < to 4.0 x normal (Nonmyeloablative Regimen 2). Negative Beta HCG ...

    Clinical Trial last updated 06/06/2016 - 10:28am.